Building Non-Communicable Eye Disease Research Capacity in India

在印度建设非传染性眼病研究能力

基本信息

  • 批准号:
    10491736
  • 负责人:
  • 金额:
    $ 22.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-20 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT India is home to over 17% of the world’s population and to 25% of those who are blind or visually impaired worldwide. Blindness and vision impairment are the fourth leading cause of years lived with disability in India and are the number one cause in those age 70 and older, a segment of the Indian population that is rapidly growing. Over 90% of vision loss in India is due to non-communicable disease, the majority of which is avoidable. Poor vision is associated with wide-reaching consequences, including an increased risk of falls, dementia, depression, disability, loss of independence, longer and more frequent hospitalizations, and increased mortality. Despite the large and growing burden of non-communicable eye disease, particularly among older adults, the shortage of research expertise in India to characterize the epidemic and understand its causes and consequences is a critical barrier to intervening effectively and reducing its population health impact. Therefore, the focus of this training program is on building clinical-epidemiological research capacity, with an emphasis on lifecourse analyses applied to the study of non-communicable eye disease (NCED) in older adults. Given the aging of the Indian population and the disproportionate impact of NCED on older Indians, it is critical to train Indian vision researchers in the research principles and methods that will enable them to effectively address this critical need. Moreover, we currently lack knowledge from a lifecourse perspective to understand the effects of early- and mid-life exposures on late-life vision and vision-related disability in India. Research specific to the Indian context is vital to determine key risk factors and disability consequences of NCED, and to develop effective contextualized interventions. The proposed research capacity building program will draw upon the exceptional institutional environments at the Aravind Eye Care System (AECS) in India and at the University of Michigan (UM), including the NIH-funded UM Claude D. Pepper Older Americans Independence Center and Clinical and Translational Science Award. The UM and AECS have a long-standing history of collaboration and educational exchanges. Based on the results of a needs assessment survey, doctoral- and masters-level training tracks have been designed to meet the needs of early- and mid-career AECS faculty who aspire to careers in clinical-epidemiological research. The aims of this program include: 1) to provide comprehensive graduate-level training in the conduct of clinical and epidemiologic research for trainees from AECS who will be equipped to take a leading role in NCED and sensory aging research in India; 2) to develop the mentoring and research education skills of AECS faculty; and 3) to establish research training opportunities at AECS that are offered to a broad regional audience. All training activities will be transitioned to AECS by the end of the 5-year grant period. Both partner institutions are dedicated to the success of this training program and to its strong potential to address the growing epidemic of NCED and visual disability among India’s rapidly aging population.
摘要 印度人口占世界总人口的17%,盲人或视力受损者占25%。 国际吧失明和视力障碍是印度残疾人生活的第四大原因 是70岁及以上人群的头号病因,这部分印度人口正在迅速 增长.在印度,超过90%的视力丧失是由于非传染性疾病,其中大部分是 可以避免的视力不佳会带来广泛的后果,包括福尔斯风险增加, 痴呆、抑郁、残疾、丧失独立性、住院时间更长、更频繁,以及 增加死亡率。尽管非传染性眼病的负担很大且不断增加, 在老年人中,印度缺乏研究专门知识来描述这种流行病并了解其 原因和后果是有效干预和降低其人口健康的关键障碍 冲击因此,该培训方案的重点是建立临床流行病学研究能力, 重点是生命过程分析应用于非传染性眼病(NCED)的研究, 老年人考虑到印度人口的老龄化和NCED对老年人的不成比例的影响, 印度人,至关重要的是要培训印度视觉研究人员的研究原则和方法, 以有效满足这一关键需求。此外,我们目前缺乏生命历程的知识, 了解早期和中期生活暴露对晚年视力和视力相关的影响 残疾在印度针对印度具体情况的研究对于确定关键风险因素和残疾至关重要 NCED的后果,并制定有效的情境化干预措施。拟议研究 能力建设计划将利用Aravind Eye Care的特殊机构环境 系统(AECS)在印度和密歇根大学(UM),包括美国国立卫生研究院资助的UM克劳德D。 胡椒老年美国人独立中心和临床和转化科学奖。um和 AECS有着悠久的合作和教育交流历史。根据一项 根据需求评估调查,设计了博士和硕士培训轨道,以满足需求 早期和中期职业生涯AECS教师谁渴望在临床流行病学研究的职业生涯。的目的 该计划包括:1)提供全面的研究生水平的培训,在临床和 流行病学研究的学员从AECS谁将配备在NCED的主导作用, 在印度的感觉老化研究; 2)发展AECS教师的指导和研究教育技能; 以及3)在AECS建立研究培训机会,提供给广泛的区域受众。所有 培训活动将在5年资助期结束时过渡到AECS。两个伙伴机构 我们致力于这一培训计划的成功,并以其强大的潜力,以解决日益增长的 NCED和视力残疾在印度快速老龄化人口中的流行。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID C MUSCH其他文献

DAVID C MUSCH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID C MUSCH', 18)}}的其他基金

Building Non-Communicable Eye Disease Research Capacity in India
在印度建设非传染性眼病研究能力
  • 批准号:
    10300299
  • 财政年份:
    2021
  • 资助金额:
    $ 22.36万
  • 项目类别:
Assessing the Interplay of Vision with Cognitive Functioning, Balance, and Falls in Middle-aged Women
评估中年女性视力与认知功能、平衡和跌倒的相互作用
  • 批准号:
    9764737
  • 财政年份:
    2019
  • 资助金额:
    $ 22.36万
  • 项目类别:
Assessing the Interplay of Vision with Cognitive Functioning, Balance, and Falls in Middle-aged Women
评估中年女性视力与认知功能、平衡和跌倒的相互作用
  • 批准号:
    9892014
  • 财政年份:
    2019
  • 资助金额:
    $ 22.36万
  • 项目类别:
Assessing the impact of glaucoma and its treatment on the person
评估青光眼及其治疗对人的影响
  • 批准号:
    8953499
  • 财政年份:
    2015
  • 资助金额:
    $ 22.36万
  • 项目类别:
Assessing the impact of glaucoma and its treatment on the person
评估青光眼及其治疗对人的影响
  • 批准号:
    9124908
  • 财政年份:
    2015
  • 资助金额:
    $ 22.36万
  • 项目类别:
Statins To Prevent Progression of Glaucoma: The STOP Glaucoma Trial
他汀类药物预防青光眼进展:停止青光眼试验
  • 批准号:
    8445488
  • 财政年份:
    2012
  • 资助金额:
    $ 22.36万
  • 项目类别:
Insights on Glaucoma from Analysis of the CIGTS Data
CIGTS 数据分析对青光眼的见解
  • 批准号:
    8289417
  • 财政年份:
    2011
  • 资助金额:
    $ 22.36万
  • 项目类别:
Insights on Glaucoma from Analysis of the CIGTS Data
CIGTS 数据分析对青光眼的见解
  • 批准号:
    8111469
  • 财政年份:
    2011
  • 资助金额:
    $ 22.36万
  • 项目类别:
Clinical and Quality of Life Insights on Glaucoma from Analyses of CIGTS Data
通过 CIGTS 数据分析了解青光眼的临床和生活质量
  • 批准号:
    7532409
  • 财政年份:
    2008
  • 资助金额:
    $ 22.36万
  • 项目类别:
Clinical and Quality of Life Insights on Glaucoma from Analyses of CIGTS Data
通过 CIGTS 数据分析了解青光眼的临床和生活质量
  • 批准号:
    7675988
  • 财政年份:
    2008
  • 资助金额:
    $ 22.36万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 22.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 22.36万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 22.36万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 22.36万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 22.36万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 22.36万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 22.36万
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 22.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 22.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 22.36万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了